- Headquarters
- Redwood City
- Employees
- 11–50
- Founded
- 2010
- Business Model
- B2B
- Website
- atreca.com
- Total Funding
- $125.0M
- Last Round
- $125.0M Series CSep 2018
About
Atreca is a clinical-stage biopharmaceutical company developing novel cancer immunotherapeutics by leveraging deep insights into the human immune response. Its proprietary Immune Repertoire Capture (IRC) technology identifies antibodies generated by the immune systems of cancer patients to discover novel therapeutic targets. Founded in 2010 and based in Redwood City, California, Atreca underwent significant workforce reductions in 2022-2023 while pivoting its pipeline toward antibody-drug conjugates.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account